Leukaemia (lymphocytic) - fludarabine (replaced by TA119)
Fludarabine for the treatment of B-cell chronic lymphocytic leukaemia
Summary
This guidance has been replaced by TA119 Leukaemia (lymphocytic) - fludarabine
Guidance documents
Implementing this guidance
Other information
About this guidance
Technology appraisals TA29
Issued: September 2001
How this guidance was produced